Piloting a Dietary Vitamin E Intervention During Pregnancy
NCT ID: NCT01661530
Last Updated: 2014-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2012-12-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, it remains to be seen whether increasing maternal vitamin E intake during pregnancy reduces the risk of childhood asthma. We are planning a large placebo controlled trial in pregnant women, to investigate whether optimisation of dietary vitamin E intake to the recommended 15mg/day reduces the likelihood of childhood asthma. We believe that a dietary intervention using vitamin E in its natural form of food is more likely to be successful and acceptable than a vitamin E supplement. We have previously demonstrated than pregnant women can optimise their vitamin E intake using a personalised dietary plan with the help of a dietitian however this intervention was complex and could not be translated into everyday use. With commercial support we have developed a range of soups containing foods naturally rich in vitamin E designed to optimise maternal vitamin E intake to 15mg/day. A range of similar tasting and looking placebo soups has also been developed. In this study we will pilot a randomised controlled trial of the active and placebo soups to ascertain whether pregnant women are willing and able to optimise their vitamin E intake during pregnancy using the soups in order to reduce the risk of their child developing asthma. optimising maternal vitamin E intake during pregnancy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Vitamins E and C in Maintaining Lung Health in People With Asthma
NCT00142610
Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma
NCT00386178
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS
NCT02104505
Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure
NCT02911688
Effect of Vitamin E Supplementation on Hemoglobin Levels in Healthy Adults
NCT02181348
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin E enhanced diet
Range of three vitamin E enhanced soups (400g/tin) containing 18-20mg vitamin in natural food form. Three portions per week
Vitamin E enhanced soup
vitamin E enhancement is by virtue of the natural vitamin E content of the food ingredients
Non-enhanced dietary intervention
Range of three similar looking and tasting soups (400g/tin) with naturally low (\<3mg) vitamin E content. Three portions per week
Non-enhanced soups
Similar looking and tasting soups with low vitamin E content by virtue of food ingredients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin E enhanced soup
vitamin E enhancement is by virtue of the natural vitamin E content of the food ingredients
Non-enhanced soups
Similar looking and tasting soups with low vitamin E content by virtue of food ingredients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Routine low risk antenatal care.
* A personal or partner history of asthma at anytime.
* Able and willing to give informed consent to participate
* Able and willing to participate in the study procedures
Exclusion Criteria
* A history of diabetes, coagulopathies or use of anticoagulants, use of clopidogrel, cholestyramine, cyclosporin A, gemfibrozil, isoniazid, orlistat, anticonvulsants.
* Any other significant disease or disorder which, in the opinion of the investigator, either puts the woman at risk because of participating in the study or may influence the results of the study, or the woman's ability to participate in the study.
* Participating in another clinical study
* Previous allocation of randomisation code in the study.
16 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aberdeen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Graham Devereux, MD
Role: PRINCIPAL_INVESTIGATOR
University of Aberdeen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aberdeen Maternity Hospital
Aberdeen, Aberdeen, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Devereux G, Turner SW, Craig LC, McNeill G, Martindale S, Harbour PJ, Helms PJ, Seaton A. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med. 2006 Sep 1;174(5):499-507. doi: 10.1164/rccm.200512-1946OC. Epub 2006 Jun 8.
Litonjua AA, Rifas-Shiman SL, Ly NP, Tantisira KG, Rich-Edwards JW, Camargo CA Jr, Weiss ST, Gillman MW, Gold DR. Maternal antioxidant intake in pregnancy and wheezing illnesses in children at 2 y of age. Am J Clin Nutr. 2006 Oct;84(4):903-11. doi: 10.1093/ajcn/84.4.903.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12/NS/0053
Identifier Type: OTHER
Identifier Source: secondary_id
2/0036/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.